Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a limited competition cooperative agreement opportunity titled "Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)." This funding aims to provide essential operations support for the NBLs located at the University of Texas Medical Branch in Galveston, Texas, and Boston University, focusing on facility maintenance, biosecurity, environmental health and safety, regulatory compliance, and specialized research support services. The NBLs play a crucial role in conducting research on hazardous biological agents, supporting biodefense efforts, and preparing for national emergencies related to infectious diseases. The total anticipated funding for this opportunity is $23 million for two awards in FY 2026, with applications due by November 7, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
Eligible Applicants
Other Eligible Applicants include the following: Eligible Organizations: The University of Texas Medical Branch at Galveston, TX and Boston University, Boston, MA Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.